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INTRODUCTION
Bone tissue is a specialized form of connective 
tissue with reparative and remodeling properties (1). 
Osteoblasts are mononuclear cells that are responsible for 
bone formation, producing most of the proteins present 
in the bone extracellular matrix (ECM) and control its 
mineralization. Osteoblasts arise from osteoprogenitor 
cells located in the periosteum and bone marrow (2). 
Fluoride promotes bone formation and it has been 
used for treating osteoporosis in some countries (2,3). 
However, its beneficial effect remains unclear because 
F is mitogenic, enhancing osteoblast number in the 
bone tissue while promoting a cytotoxic effect, reducing 
mineralization and mineral apposition rate (2). In this 
context, it was shown that the treatment with F enhanced 
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This study evaluated the influence of fluoride on cell viability and activity of matrix metalloproteinases (MMP) -2 and -9 secreted 
by preosteoblasts. Preosteoblasts (MC3T3-E1 murine cell line) were cultured in MEM medium supplement with 10% Fetal Bovine 
Serum (FBS) and nucleosides/ribonucleosides without ascorbic acid. Adherent cells were treated with different concentrations of F 
(as sodium fluoride-NaF) in medium (5 x 10-6 M, 10-5 M, 10-4 M and 10-3 M) for 24, 48, 72 and 96 h at 37oC, 5% CO2. Control cells 
were cultivated in MEM only. After each period, preosteoblast viability was assessed by MTT assay. MMP-2 and -9 activities were 
performed by gel zymography. Also, alkaline phosphatase (ALP) activity was quantified by colorimetry in all experimental groups. 
It was shown that cultured cells with the highest dose of F (10-3 M) for 96 h decreased preosteoblast viability while lower doses of F 
did not alter it, when compared to untreated cells. No differences were observed in ALP activity among groups. Moreover, compared 
to control, the treatment of cells with F at low dose slightly increased MMP-2 and -9 activities after 24 h. It was concluded that F 
modulates preosteoblast viability in a dose-dependent manner and also may regulate extracellular matrix remodeling.
Key Words: metalloproteinase, phosphatase, fluoride.
both cortical bone thickness and bone mass (4).
F may alter osteoblast activity, acting either in a 
systemic way or in fluorapatite crystals (5), modulating 
the amount of bone mass in rats in a dose-dependent 
manner (6).
ECM turnover is clearly involved during bone 
remodeling and matrix metalloproteinases (MMPs) 
govern these events (7). MMPs are zinc-dependent 
endopeptidases. Collectively they are capable of 
degrading all kinds of extracellular matrix proteins. 
Also, they play an important role in tissue remodeling 
associated with various physiological and pathological 
processes such as morphogenesis, angiogenesis, tissue 
repair, cirrhosis, arthritis and metastasis (8,9). Normal 
human osteoblasts express MMP-2 and in vitro, they 
secrete abundant MMP-2. MMP-9 is produced by both 
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osteoblasts and osteoclasts in developing and remodeling 
bone (10). Recently, osteoblast-derived MMPs were 
shown to play a role in the bone metabolism by the 
degradation of bone matrix (10).
Despite the numerous studies undertaken on 
osteoblast/fluoride interactions, their regulation on ECM 
remodeling remains to be understood. The present study 
was undertaken to evaluate the effect of F on osteoblast 
viability by MTT assay, and MMP-2 and -9 activities 
by zymography gel analysis.
MATERIAL AND METHODS
Cell Culture
MC3T3-E1 preosteoblasts (ATCC murine cell 
line) were cultivated in MEM (Minimum Essential 
Medium) (Invitrogen, Carlsbad, CA, USA) medium 
supplemented with 10% fetal bovine serum (FBS) 
(Invitrogen), 1% penicillin/streptomycin (Sigma, St. 
Louis, MO, USA) and nucleosides/ribonucleosides 
(Sigma), with no ascorbic acid (11). Cells plated at the 
density of 5x102 in 96-well plates (TPP-Techno Plastic 
Products, Trasadingen, Switzerland) were incubated 
at 37°C, 5% CO2. After 8 h (time to allow cellular 
adherence), the adhered cells were treated with different 
concentrations of F (as NaF) (5x10-6M, 10-5M, 10-4M 
and 10-3M) prepared in MEM 10% FBS. The medium 
containing F was replaced every other day. Control cells 
received only MEM medium 10% FBS.
MTT Assay
Cells were plated and treated as described 
above for 24, 48, 72 and 96 h. After each time point, 
the supernatants were removed and new medium (no 
serum) was added followed by the addition of 10 μL of 
MTT (Sigma) (0.5 mg/mL in PBS) and incubation for 
4 h at 37°C. Formazan precipitate was solubilized with 
100 μL/well of 10% SDS-HCl 0.01 M. The plates were 
read in spectrophotometer at 540 nm. Each condition 
was done in triplicate (3 wells).
Extraction and Quantification of Secreted Proteins
Cells were treated with or without different 
concentrations of F in MEM 10% FBS (10-3, 10-4 and 
10-5 M) for 24 and 48 h (12). Supernatants were collected 
and the secreted proteins were quantified by Hartree 
modified- Lowry (13).
Zymography Gel Analysis
Conditioned supernatants were obtained and 15 
µg of protein were used for zymography gel loading. As 
controls, molecular weight standards and recombinant 
MMP-2 and MMP-9 proteins (Calbiochem; Merck, 
Darmstadt, Germany) were used. The gels were stained 
with Coomassie Blue G-250 (0.5%), scanned using 
the Imagemaster scanner (GE Healthcare®, Uppsala, 
Sweden) followed by Kodak Molecular Imaging 
Software (Kodak Co., Rochester, NY, USA) for analysis. 
The results show the mean of 3 independent gels, as 
reported by Hannas et al. (14).
ALP Activity Measurement
The commercial kit “Doles” (Dr. Jarbas Doles 
Laboratories Ltda., Goiânia, GO, Brazil) was used. 
Samples, standards and reagents were used according to 
manufacturer’s instructions. Samples were obtained by 
colleting total cellular extracts. The 96-well plates were 
read at 410 nm (FLUOstar OPTIMA; BMG Labtech, 
Offenburg, Germany). The data are shown as mean of 
UI/L where 1 UI is equivalent to 0.01667 μkat/L.
Statistical Analysis
Parametric analysis was performed by analysis 
of variance followed by Tukey’s test. Statistical 
significance was considered if p<0.05.
RESULTS
Fluoride Alters Cell Viability in a Dose- and Time-
Dependent Manner
In order to evaluate the effect of fluoride on cell 
viability, MTT assay (Fig. 1) was performed. As expected, 
preosteoblast presented a linear increased viability when 
cultured in medium during the experimental period (up 
to 96 h) (Fig. 1). The treatment of the cells with 10-4 and 
10-5 M doses of NaF for 24 h decreased their proliferation 
compared to untreated cells (p<0.05). However, lower 
doses of NaF (1x10-5 and 5x10-6 M) had no effect on 
preosteoblast viability at 72 and 96 h. Moreover, NaF at 
a higher dose (10-3 M) presented a tendency to decrease 
cell proliferation, which was significantly after 96 h 
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(p<0.01) (Fig. 1).
Fluoride Slightly Modulates MMP-2 and -9 Activities
Untreated preosteoblasts induced MMP-2 and 
-9 activities as judged by zymography gels, where the 
former was more pronounced than the last after both 24 
and 48 h time points. Although not statistically significant 
(p>0.05), treating the cells with high concentrations of 
NaF (10-3 M and 10-4 M) lead to greater MMP-2 activity 
after 24 h compared to untreated cells, while the lowest 
dose (10-5 M) barely altered its activity (Fig. 2). In 
this period, for MMP-9 (Fig. 3) only the group treated 
with 10-4M seemed to increase its activity (p>0.05). 
Moreover, the treatment of cells with F for 48h did not 
modify both MMP-2 and -9 activities when compared 
to control groups (Figs. 2 and 3).
Fluoride does not Modulate ALP Activity in 
Preosteoblasts
As shown in Table 1, the treatment of cells for 
24 and 48 h with either low or high concentrations of 
NaF was not able to modify ALP activity.
DISCUSSION
The present study demonstrates the important role 
that fluoride plays in preosteoblast metabolism. A high 
dose of fluoride (10-3M) decreased cell viability while 
low doses did not change it, judging by the MTT assay. 
Moreover, fluoride at both 10-3 M and 10-4 M presented a 
tendency to enhance MMP-2 and MMP-9 activity after 
24 h and no differences were observed up to this period. 
Similarly, it has been shown that fluoride at low doses 
(as NaF) increases osteoblast proliferation (15) and bone 
mass (4). Also, proliferation of caprine osteoblasts was 
up-modulated after treatment with fluoride at 10-8 to 10-
5M and down-regulated at 10-4 to 10-3 M of NaF (16). The 
effect of fluoride on proliferation has also been shown 
in other cell types. In this context, Yan 
et al. (17) showed that NaF at doses 
of 4, 16 and 64 µM led to increased 
ameloblast proliferation, while the 
dose of 1,024 µM promoted apoptosis 
impairing osteoblast survival. The 
obtained results corroborate others, 
showing that fluoride affects cell 
proliferation in a dose-dependent 
fashion. No significant enhancement of preosteoblast 
viability was found after treatment of cells with low 
doses. In this context, it is known that MTT assay has 
limitations that may impair its sensibility (18). Fluoride 
has been used in clinical trials for osteoporosis (2,3). 
Several treatment profiles, including different doses and 
long-term protocols, have been tested resulting in both 
beneficial (primarily at low doses) and impaired effects 
(3). The latter has been reported after long-term excessive 
fluoride intake (i.e. endemic areas) leading to what it is 
known as skeletal fluorosis (19). Recently, Inoue et al. 
(20) showed that treating osteoblasts and odontoblasts 
with low concentration of fluoride promoted greater and 
faster bone formation than with high concentration, in a 
dose-dependent fashion. The dual fluoride impacts on 
skeletal health, promoting bone formation or skeletal 
fluorosis can be highlighted by its dose-dependent 
effect in preosteoblasts. This biphasic effect of fluoride 
Figure 1. Effect of NaF on preosteoblast viability. MC3T3-E1 
preosteoblasts were cultured in medium in an absence (control 
group) or presence of different concentrations of NaF (10-3, 10-4, 
10-5 and 5 x 10-6 M). After 24, 48, 72 and 96 h MTT assay was 
performed. * p<0.05; *** p<0.01.
Table 1. Alkaline phosphatase activity (UI/L).
Period
Group
Control 10-5M F 10-4M F 10-3M F
24 h 6.182a ± 1.952b 6.191± 1.949 6.164 ± 1.979 6.155 ± 1.957
48 h 6.165 ± 1.944 6.195± 1.974 6.179 ± 1.974 6.167 ± 1.974
aMean. bStandard deviation.
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suggested that fluoride can affect cells by multiple 
pathways, some of which are more sensitive to lower 
concentrations of fluoride and others that require higher 
fluoride concentrations. Several studies have shown that 
millimolar levels of fluoride might induce apoptosis in 
many cell types, including hepatic cells, epithelial lung 
cells, human leukemia HL-60 cells and ameloblast-
lineage cells (17,21). In addition, other authors showed 
that fluoride does not induce DNA damage (22). In 
this study it is proposed that F at 10-3 M might trigger 
apoptosis by activating caspases signaling pathways.
The impact of fluoride on ALP activity is still 
controversial and it seems to be dependent on the 
experimental design. Both up and down modulation have 
been found after fluoride treatment using osteoblasts 
(15-17). In the present study, there were no differences 
among the control and treated preosteoblasts. It is well 
known that ALP activity is up-regulated when culturing 
preosteoblasts under differentiation (23). Thus, this 
may be explained by the fact that the undifferentiated 
preosteoblasts have such low ALP activity that impairs 
either up or down modulation by fluoride.
As fluoride is also known to alter mineralization 
within the bone, it was examined whether fluoride 
has impact on remodeling matrix activity. In control 
preosteoblasts, MMP-2 activity was more pronounced 
Figure 3. Effect of NaF on MMP-9 activity. Representative gel 
(48 h) is shown in A. MC3T3-E1 preosteoblast were cultured in 
medium only (control) or in a presence of different doses of NaF 
(10-3, 10-4 and 10-5 M). The supernatants were obtained at (B) 24 
and (C) 48 h and used for zymography gel loading (15 μg protein). 
The gels were scanned and the images were used for densitometric 
analysis using the Kodak Molecular Imaging Software. The active 
form (~77 kDa) was used for the densitometric analysis. The 
results are shown as arbitrary numbers (Mean ± SD). The gels 
were conducted in triplicate. Control bands were standardized 
as number 1.
Figure 2. Effect of NaF on MMP-2 activity. Representative gel 
(24 h) is shown in A. MC3T3-E1 preosteoblast were cultured in 
medium only (control) or in presence of different doses of NaF 
(10-3, 10-4 and 10-5 M). The supernatants were obtained at (B) 24 
and (C) 48 h and used for zymography gel loading (15 μg protein). 
The gels were scanned and the images were used for densitometric 
analysis using the Kodak Molecular Imaging Software. The active 
form (~66 kDa) was used for the densitometric analysis. The 
results are shown as arbitrary numbers (Mean ± SD). The gels 
were conducted in triplicate. Control bands were standardized 
as number 1.
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than MMP-9. Also, treating the cells with fluoride 
slightly increased both MMP-2 and -9 after 24 h 
incubation with no effect up to this time point, compared 
to untreated control cells. It is worth emphasizing that, 
since this difference was not statistically significant 
(n=3), fluoride might have some biological effect on 
ECM remodeling. Little is known about the effect of 
fluoride on bone-producing MMPs. Waddington and 
Langley (24) showed that the presence of fluoride altered 
expression of MMP-1 and MMP-9 when mineralizing 
bone cells in vitro. The impact of fluoride on individual 
MMP-2 and -9 activities in bone formation has been 
reported in previous studies conducted by our research 
group. It was shown that the treatment of rats with 5 
ppm F increased MMP-2 activity in alveolar bone on 
day 7 and of MMP-9 on day 30 (unpublished data). The 
possibility that fluoride could have greater affect in the 
osteogenic environment cannot be ruled out, since an 
increase in MMP activities has been reported during 
MC3T3-E1 preosteoblast differentiation (11). Also, 
there is a possibility that other MMP, besides MMP-
2 and -9, have been modulated by fluoride in these 
cells. Moreover, the MMPs are inhibited by specific 
endogenous tissue inhibitors of metalloproteinases 
(TIMPs), which comprise a family of four protease 
inhibitors: TIMP1, TIMP2, TIMP3 and TIMP4. 
Enhancement of MMP activity may be a consequence 
of functional MMP stimulation or of TIMP deactivation 
(25). In this study, TIMP expression was evaluated 
because no significant modulation of MMP-2 and -9 
after treatment was found. Therefore, the little influence 
of fluoride on MMP-2 and MMP-9 activity is likely to 
influence the composition of the remodeling matrix and 
subsequent mineralization. These results suggest that in 
response to fluoride, preosteoblasts may contribute to 
the process of active matrix degradation followed by 
bone formation by secretion and activation of MMPs.
RESUMO
Neste estudo, buscou-se avaliar a influência do fluoreto (F) na 
viabilidade celular e atividade das metaloproteinases de matriz 
(MMP) -2 e -9 secretado pelos pré-osteoblastos. Pré-osteoblastos 
(linhagem celular MC3T3-E1 murina) foram cultivados em 
meio MEM suplementado com 10% de soro fetal bovino (FBS) 
e nucleosídeos/ribonucleosídeos sem ácido ascórbico. Células 
aderidas foram tratadas com diferentes concentrações de F (na 
forma de fluoreto de sódio-NaF) em meio (5 x 10-6 M, 10-5 M, 10-4 
M e 10-3 M) por 24, 48, 72 e 96 h a 37ºC, 5 % de CO2. Células 
do grupo controle foram cultivadas apenas em MEM. Após cada 
período, a viabilidade dos pré-osteoblastos foi avaliada por MTT. A 
atividade das MMP-2 e -9 foram analisadas pela zimografia. Além 
disso, a atividade da fosfatase alcalina (FA) foi quantificada por 
colorimetria em todos os grupos experimentais. Foi demonstrado 
que as células cultivadas com a maior dose de F (10-3 M) no 
período de 96 h tiveram sua viabilidade comprometida, enquanto 
doses mais baixas de F não a alteraram significativamente, quando 
comparado com células não tratadas. Não foi observada diferença 
na atividade da FA entre os grupos. Além disso, o tratamento de 
células com F em baixas doses, comparado ao grupo controle, 
promoveu um pequeno aumento da atividade das MMP-2 e -9 
após 24 h. Pode-se concluir que o F modula a viabilidade de pré-
osteoblastos de uma maneira dose-dependente e também pode 
regular a remodelação da matriz extracelular.
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